1 |
Mattingly, B.C. and Buechner, M. (2011). The FGD homologue EXC-5 regulates apical trafficking in C. elegans tubules. Dev. Biol. 359, 59-72.
DOI
|
2 |
Nam, S.H., Hong, Y.B., Hyun, Y.S., Nam, D.E., Kwak, G., Hwang, S.H., Choi, B.O., and Chung, K.W. (2016). Identification of genetic causes of inherited peripheral neuropathies by targeted gene panel sequencing. Mol. Cells 39, 382-388.
DOI
|
3 |
Pareyson, D., Saveri, P., and Pisciotta, C. (2017). New developments in Charcot-Marie-Tooth neuropathy and related diseases. Curr. Opin. Neurol. 30, 471-480.
DOI
|
4 |
Pastore, M. and Calcagnì, A. (2019). Measuring distribution similarities between samples: a distribution-free overlapping index. Front. Psychol. 10, 1089.
DOI
|
5 |
Pierce, S.B., Chisholm, K.M., Lynch, E.D., Lee, M.K., Walsh, T., Opitz, J.M., Li, W., Klevit, R.E., and King, M.C. (2011). Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome. Proc. Natl. Acad. Sci. U. S. A. 108, 6543-6548.
DOI
|
6 |
Santel, A. and Fuller, M.T. (2001). Control of mitochondrial morphology by a human mitofusin. J. Cell Sci. 114, 867-874.
DOI
|
7 |
Schwartz, N.U. (2019). Charcot-Marie-Tooth 2F (Hsp27 mutations): a review. Neurobiol. Dis. 130, 104505.
DOI
|
8 |
Shen, X.N., Sznitman, J., Krajacic, P., Lamitina, T., and Arratia, P.E. (2012). Undulatory locomotion of Caenorhabditis elegans on wet surfaces. Biophys. J. 102, 2772-2781.
DOI
|
9 |
Sonnichsen, B., Koski, L.B., Walsh, A., Marschall, P., Neumann, B., Brehm, M., Alleaume, A.M., Artelt, J., Bettencourt, P., Cassin, E., et al. (2005). Fullgenome RNAi profiling of early embryogenesis in Caenorhabditis elegans. Nature 434, 462-469.
DOI
|
10 |
Storey, J.D. (2002). A direct approach to false discovery rates. J. R. Stat. Soc. Series B Stat. Methodol. 64, 479-498.
DOI
|
11 |
Tanaka, Y. and Hirokawa, N. (2002). Mouse models of Charcot-Marie- Tooth disease. Trends Genet. 18, S39-S44.
DOI
|
12 |
Vester, A., Velez-Ruiz, G., McLaughlin, H.M., NISC Comparative Sequencing Program, Lupski, J.R., Talbot, K., Vance, J.M., Züchner, S., Roda, R.H., Fischbeck, K.H., et al. (2013). A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo. Hum. Mutat. 34, 191-199.
DOI
|
13 |
Yemini, E., Jucikas, T., Grundy, L.J., Brown, A.E., and Schafer, W.R. (2013). A database of Caenorhabditis elegans behavioral phenotypes. Nat. Methods 10, 877-879.
DOI
|
14 |
Weedon, M.N., Hastings, R., Caswell, R., Xie, W., Paszkiewicz, K., Antoniadi, T., Williams, M., King, C., Greenhalgh, L., Newbury-Ecob, R., et al. (2011). Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease. Am. J. Hum. Genet. 89, 308-312.
DOI
|
15 |
Wen, Q., Gao, S., and Zhen, M. (2018). Caenorhabditis elegans excitatory ventral cord motor neurons derive rhythm for body undulation. Philos. Trans. R. Soc. Lond. B Biol. Sci. 373, 20170370.
DOI
|
16 |
Won, S.Y., Choi, B.O., Chung, K.W., and Lee, J.E. (2019). Zebrafish is a central model to dissect the peripheral neuropathy. Genes Genomics 41, 993-1000.
DOI
|
17 |
Wright, M.W., Eyre, T.A., Lush, M.J., Povey, S., and Bruford, E.A. (2005). HCOP: the HGNC comparison of orthology predictions search tool. Mamm. Genome 16, 827-828.
DOI
|
18 |
Yamaguchi, M. and Takashima, H. (2018). Drosophila Charcot-Marie-Tooth disease models. Adv. Exp. Med. Biol. 1076, 97-117.
DOI
|
19 |
Acunzo, J., Katsogiannou, M., and Rocchi, P. (2012). Small heat shock proteins HSP27 (HspB1), -crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death. Int. J. Biochem. Cell Biol. 44, 1622-1631.
DOI
|
20 |
Antonellis, A., Ellsworth, R.E., Sambuughin, N., Puls, I., Abel, A., Lee-Lin, S.Q., Jordanova, A., Kremensky, I., Christodoulou, K., Middleton, L.T., et al. (2003). Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am. J. Hum. Genet. 72, 1293-1299.
DOI
|
21 |
Baek, J.H., Cosman, P., Feng, Z., Silver, J., and Schafer, W.R. (2002). Using machine vision to analyze and classify Caenorhabditis elegans behavioral phenotypes quantitatively. J. Neurosci. Methods 118, 9-21.
DOI
|
22 |
Byrne, J.J., Soh, M.S., Chandhok, G., Vijayaraghavan, T., Teoh, J.S., Crawford, S., Cobham, A.E., Yapa, N.M.B., Mirth, C.K., and Neumann, B. (2019). Disruption of mitochondrial dynamics affects behaviour and lifespan in Caenorhabditis elegans. Cell. Mol. Life Sci. 76, 1967-1985.
DOI
|
23 |
Ben Arous, J., Laffont, S., and Chatenay, D. (2009). Molecular and sensory basis of a food related two-state behavior in C. elegans. PLoS One 4, e7584.
DOI
|
24 |
Bragato, C., Gaudenzi, G., Blasevich, F., Pavesi, G., Maggi, L., Giunta, M., Cotelli, F., and Mora, M. (2016). Zebrafish as a model to investigate dynamin 2-related diseases. Sci. Rep. 6, 20466.
DOI
|
25 |
Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77, 71-94.
DOI
|
26 |
Zhao, C., Takita, J., Tanaka, Y., Setou, M., Nakagawa, T., Takeda, S., Yang, H.W., Terada, S., Nakata, T., Takei, Y., et al. (2001). Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105, 587-597.
DOI
|
27 |
Zhen, M. and Samuel, A.D. (2015). C. elegans locomotion: small circuits, complex functions. Curr. Opin. Neurobiol. 33, 117-126.
DOI
|
28 |
Zuchner, S., Mersiyanova, I.V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E.L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J., et al. (2004). Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 36, 449-451.
DOI
|
29 |
Edwards, S.L., Yorks, R.M., Morrison, L.M., Hoover, C.M., and Miller, K.G. (2015). Synapse-assembly proteins maintain synaptic vesicle cluster stability and regulate synaptic vesicle transport in Caenorhabditis elegans. Genetics 201, 91-116.
DOI
|
30 |
d'Ydewalle, C., Krishnan, J., Chiheb, D.M., Van Damme, P., Irobi, J., Kozikowski, A.P., Vanden Berghe, P., Timmerman, V., Robberecht, W., and Van Den Bosch, L. (2011). HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat. Med. 17, 968-974.
DOI
|
31 |
England, J.D. and Asbury, A.K. (2004). Peripheral neuropathy. Lancet 363, 2151-2161.
DOI
|
32 |
Eschenbacher, W.H., Song, M., Chen, Y., Bhandari, P., Zhao, P., Jowdy, C.C., Engelhard, J.T., and Dorn, G.W., 2nd (2012). Two rare human mitofusin 2 mutations alter mitochondrial dynamics and induce retinal and cardiac pathology in Drosophila. PLoS One 7, e44296.
DOI
|
33 |
Jordanova, A., Irobi, J., Thomas, F.P., Van Dijck, P., Meerschaert, K., Dewil, M., Dierick, I., Jacobs, A., De Vriendt, E., Guergueltcheva, V., et al. (2006). Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat. Genet. 38, 197-202.
DOI
|
34 |
Evgrafov, O.V., Mersiyanova, I., Irobi, J., Van Den Bosch, L., Dierick, I., Leung, C.L., Schagina, O., Verpoorten, N., Van Impe, K., Fedotov, V., et al. (2004). Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat. Genet. 36, 602-606.
DOI
|
35 |
Hafezparast, M., Klocke, R., Ruhrberg, C., Marquardt, A., Ahmad-Annuar, A., Bowen, S., Lalli, G., Witherden, A.S., Hummerich, H., Nicholson, S., et al. (2003). Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300, 808.
DOI
|
36 |
Harris, T.W., Arnaboldi, V., Cain, S., Chan, J., Chen, W.J., Cho, J., Davis, P., Gao, S., Grove, C.A., Kishore, R., et al. (2020). WormBase: a modern model organism information resource. Nucleic Acids Res. 48, D762-D767.
|
37 |
Hong, Y.B., Kang, J., Kim, J.H., Lee, J., Kwak, G., Hyun, Y.S., Nam, S.H., Hong, H.D., Choi, Y.R., Jung, S.C., et al. (2016). DGAT2 mutation in a family with autosomal-dominant early-onset axonal Charcot-Marie-Tooth disease. Hum. Mutat. 37, 473-480.
DOI
|
38 |
Inman, H.F. and Bradley, E.L., Jr. (1989). The overlapping coefficient as a measure of agreement between probability distributions and point estimation of the overlap of two normal densities. Commun. Stat. Theory Methods 18, 3851-3874.
DOI
|
39 |
Lee, A.J., Nam, D.E., Choi, Y.J., Nam, S.H., Choi, B.O., and Chung, K.W. (2020). Alanyl-tRNA synthetase 1 (AARS1) gene mutation in a family with intermediate Charcot-Marie-Tooth neuropathy. Genes Genomics 42, 663-672.
DOI
|
40 |
Kim, J.Y., Woo, S.Y., Hong, Y.B., Choi, H., Kim, J., Choi, H., Mook-Jung, I., Ha, N., Kyung, J., Koo, S.K., et al. (2016). HDAC6 Inhibitors rescued the defective axonal mitochondrial movement in motor neurons derived from the induced pluripotent stem cells of peripheral neuropathy patients with HSPB1 mutation. Stem Cells Int. 2016, 9475981.
|
41 |
Lee, H.J., Park, J., Nakhro, K., Park, J.M., Hur, Y.M., Choi, B.O., and Chung, K.W. (2012). Two novel mutations of GARS in Korean families with distal hereditary motor neuropathy type V. J. Peripher. Nerv. Syst. 17, 418-421.
DOI
|
42 |
Long, R.T., Peng, J.B., Huang, L.L., Jiang, G.P., Liao, Y.J., Sun, H., Hu, Y.D., and Liao, X.H. (2019). Augmenter of liver regeneration alleviates renal hypoxiareoxygenation injury by regulating mitochondrial dynamics in renal tubular epithelial cells. Mol. Cells 42, 893-905.
DOI
|